Kymera Therapeutics (KYMR) Receivables (2020 - 2026)
Kymera Therapeutics' Receivables came in at $20 million for Q2 2026, down 50.0% from $40 million a year earlier.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2024, Kymera Therapeutics' Receivables was $1.89 million, down 91.6% from FY2023.
- Receivables carries a four-year compound annual growth rate of -5.1% (FY2020 to FY2024).
- Going back by year, Receivables was $22.56 million in FY2023 (+344.7%), $5.07 million in FY2022, $270,000 in FY2021 (-88.4%) and $2.33 million in FY2020.
- The Q2 2026 figure represents the lowest quarterly Receivables since Q4 2024.
- Year-over-year, Receivables increased in 1 of the last four quarters, with growth averaging 170.0%.
- The fastest year-over-year change in Receivables over five years came in Q1 2025 (growth of 885.2%), and the weakest in Q4 2024 (a decline of 90.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Kymera Therapeutics | 11.09 Bn | 8.39 Bn | - | 20.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 4.06 Mn |
| Dec 31, 2023 | 18.76 Mn |
| Sep 30, 2023 | 7.58 Mn |
| Jun 30, 2023 | 8.24 Mn |
| Mar 31, 2023 | 6.64 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 5.78 Mn |
| Jun 30, 2022 | 4.77 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 3.17 Mn |
| Jun 30, 2021 | 1.81 Mn |
| Mar 31, 2021 | 2.63 Mn |
| Dec 31, 2020 | 2.29 Mn |
API Access
Kymera Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();